Unveiling the complex mechanisms of cancer
Indivumed is a global oncology company and your resource for precision oncology. We are committed to shaping a future with individualized cancer therapy.
Our goal is to illuminate biological correlates in cancer, thereby supporting the precision oncology of the future today. Utilizing high-quality biospecimens and data and a multi-omics analysis approach we offer specialized products and services that support our customers in biomarker and target discovery, drug development, clinical trials, and more.
Tissue: Mean ischemia time <10 minutes.
Blood: Immediately cooled to 4–8°C and processed in <4 hours.
Indivumed is your partner for:
- Basic research
- Biomarker identification and validation
- Target identification and validation
- Drug development
- IVD/CDx development
The Indivumed Standard
The uniquely high quality of our samples enables a comprehensive multi-omics analysis approach.
To ensure this level of quality, we apply over 100 standard operating procedures to the collection and curation of our wide variety of biospecimens and corresponding clinical data – worldwide. The SOPs have been developed through decades of experience working side-by-side with surgeons and pathologists in our global Clinical Network.
How can we support your oncology research?
Using breakthrough techniques we are able to provide complex data and precisely describe cellular mechanisms to a depth never achieved before.
A comprehensive source for biobank products, laboratory services, and research partnerships.
IndivuServ utilizes our samples to offer quality biobank products and services, supporting biomarker discovery and validation, drug development, and companion diagnostics.
A unique asset for making discoveries in multi-omics based oncology R&D.
IndivuType helps you discover and validate novel molecular drug targets and biomarkers, while simultaneously putting them in a comprehensive biological and clinical context.
By integrating unique resources, global partnerships, and decades of experience, we have developed a comprehensive understanding of cancer and its processes. This allows us to act as your trusted service provider or see eye-to-eye as your development partner for precision oncology.